Cost Effectiveness of Riluzole in Amyotrophic Lateral Sclerosis

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.16, Iss.2, 1999-08, pp. : 153-163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Amyotrophic lateral sclerosis, excitotoxicity and riluzole

By Obrenovitch T.P.

Trends in Pharmacological Sciences, Vol. 19, Iss. 1, 1998-01 ,pp. : 9-9

Elsevier

Access to resources Recommend Favorite

Riluzole, Neuroprotection and Amyotrophic Lateral Sclerosis

Current Medicinal Chemistry, Vol. 17, Iss. 18, 2010-06 ,pp. : 1942-1959

Bentham Science Publishers

Access to resources Recommend Favorite

The tolerability of riluzole in the treatment of patients with amyotrophic lateral sclerosis

By Bensimon Gilbert Doble Adam

Expert Opinion on Drug Safety, Vol. 3, Iss. 6, 2004-11 ,pp. : 525-534

Informa Healthcare

Access to resources Recommend Favorite

Cost Effectiveness of Treatments for Amyotrophic Lateral Sclerosis: A Review of the Literature

By Ginsberg G.

PharmacoEconomics, Vol. 20, Iss. 6, 2002-06 ,pp. : 367-387

Adis International

Access to resources Recommend Favorite

Riluzole Use During Pregnancy in a Patient with Amyotrophic Lateral Sclerosis: a Case Report

By Kawamichi Y Makino Y Matsuda Y Miyazaki K Uchiyama S Ohta H

The Journal of International Medical Research, Vol. 38, Iss. 2, 2010-03 ,pp. : 720-726

Field House Publishing

Access to resources Recommend Favorite